Severe weakness complicating status asthmaticus despite minimal duration of neuromuscular paralysis
- 20 September 2008
- journal article
- research article
- Published by Springer Nature in Intensive Care Medicine
- Vol. 35 (1) , 157-160
Abstract
Objective Mechanically ventilated patients with status asthmaticus who undergo prolonged paralysis are at risk for severe weakness due to myopathy. In the mid-1990s, we changed our usual method of achieving tolerance of ventilatory support in asthmatic patients from continuous paralysis to deep sedation. This study examines the impact of this change in practice on the development of clinically significant weakness in status asthmaticus. Design and setting Retrospective cohort study in university-affiliated county hospital. Patients Mechanically ventilated asthmatic patients seen before (n = 96) and after (n = 74) a clinical practice change in 1995 that markedly restricted use of paralytics. Results The duration of neuromuscular paralysis declined sharply after 1995 (23.7 ± 42.2 vs. 1.8 ± 4.0 h, P < 0.001), but this was not associated with a significant difference in the incidence of weakness (21 vs. 14%, P = 0.23). Within the post-1995 cohort, there was no significant difference in the duration of paralysis for weak and non-weak patients (3.5 ± 6.2 vs. 1.5 ± 3.5 h, P = 0.10). However, weak patients had a much longer duration of mechanical ventilation than did patients without weakness (11.9 ± 3.6 vs. 1.9 ± 1.8 days, P < 0.001). Conclusion Mechanically ventilated patients with status asthmaticus who are immobilized for prolonged periods of time by deep sedation remain at risk for clinically significant weakness.Keywords
This publication has 19 references indexed in Scilit:
- Respiratory weakness is associated with limb weakness and delayed weaning in critical illness*Critical Care Medicine, 2007
- Steroid-induced myopathy in patients intubated due to exacerbation of chronic obstructive pulmonary diseaseIntensive Care Medicine, 2004
- Muscle Weakness in Mechanically Ventilated Patients With Severe AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 1996
- Myopathy in Severe AsthmaAmerican Review of Respiratory Disease, 1992
- Acute Myopathy during Treatment of Status Asthmaticus with Corticosteroids and Steroidal Muscle RelaxantsChest, 1992
- Acute myopathy with selective degeneration of myosin filaments following status asthmaticus treated with methylprednisolone and vecuroniumNeuromuscular Disorders, 1992
- Myopathy with thick filament (myosin) loss following prolonged paralysis with vecuronium during steroid treatmentMuscle & Nerve, 1991
- Risk factors for hydrocortisone myopathy in acute severe asthmaRespiratory Medicine, 1990
- Acute Myopathy in Severe Acute Asthma Treated with Intravenously Administered CorticosteroidsAmerican Review of Respiratory Disease, 1988
- SEVERE MYOPATHY AFTER STATUS ASTHMATICUSThe Lancet, 1977